Skip to main content

Advertisement

SpringerLink
Log in

MiR-183 promotes growth of non-small cell lung cancer cells through FoxO1 inhibition

  • Research Article
  • Published:
Tumor Biology

Abstract

Non-small cell lung cancer (NSCLC) is a prevalent cancer in lung of high incidence. NSCLCs often appear to be fast growing, which renders comprehension of the mechanisms underlying the growth of NSCLC extremely critical. Previous study has addressed a role of microRNA (miR) family member, miR-183, in the regulation of the invasiveness of NSCLC, whereas the role of miR-183 in the growth control of NSCLC is not clear. Here, we analyzed the regulation of FoxO1 by miR-183 in vitro using luciferase-reporter assay. We also analyzed the effects of miR-183 on NSCLC cell growth in vitro using a microculture tetrazolium (MTT) assay and in vivo by visualizing tumor growth using bioluminescence assay. We found that overexpression of miR-183 in NSCLC cells decreased FoxO1 protein levels, whereas inhibition of miR-183 increased FoxO1 protein levels without affecting FoxO1 transcripts. Moreover, miR-183 bound to FoxO1 mRNA to prevent its translation through its 3′untranslated region (UTR). Furthermore, administration of miR-183 suppressed FoxO1 levels in NSCLC, resulting in a significant increase in NSCLC growth in vitro and in vivo, while administration of antisense of miR-183 significantly increased FoxO1 levels in NSCLC resulting in a significant decrease in NSCLC growth. Taken together, our data demonstrate that miR-183/FoxO1 axis may be a novel therapeutic target for regulating the growth of NSCLC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Caramori G, Casolari P, Cavallesco GN, Giuffre S, Adcock I, Papi A. Mechanisms involved in lung cancer development in copd. Int J Biochem Cell Biol. 2011;43:1030–44.

    Article  CAS  PubMed  Google Scholar 

  2. Buttery RC, Rintoul RC, Sethi T. Small cell lung cancer: the importance of the extracellular matrix. Int J Biochem Cell Biol. 2004;36:1154–60.

    Article  CAS  PubMed  Google Scholar 

  3. Jian H, Zhao Y, Liu B, Lu S. Sema4b inhibits mmp9 to prevent metastasis of non-small cell lung cancer. Tumour Biol. 2014;35:11051–6.

    Article  CAS  PubMed  Google Scholar 

  4. Jian H, Zhao Y, Liu B, Lu S. Sema4b inhibits growth of non-small cell lung cancer in vitro and in vivo. Cell Signal. 2015;27:1208–13.

    Article  CAS  PubMed  Google Scholar 

  5. Pei J, Lou Y, Zhong R, Han B. Mmp9 activation triggered by epidermal growth factor induced foxo1 nuclear exclusion in non-small cell lung cancer. Tumour Biol. 2014;35:6673–8.

    Article  CAS  PubMed  Google Scholar 

  6. Sicard F, Gayral M, Lulka H, Buscail L, Cordelier P. Targeting mir-21 for the therapy of pancreatic cancer. Mol Ther. 2013;21:986–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Tavano F, di Mola FF, Piepoli A, Panza A, Copetti M, Burbaci FP, et al. Changes in mir-143 and mir-21 expression and clinicopathological correlations in pancreatic cancers. Pancreas. 2012;41:1280–4.

    Article  CAS  PubMed  Google Scholar 

  8. Ali S, Ahmad A, Banerjee S, Padhye S, Dominiak K, Schaffert JM, et al. Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of mir-200 and mir-21 expression by curcumin or its analogue cdf. Cancer Res. 2010;70:3606–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Zhao H, Guo M, Zhao G, Ma Q, Ma B, Qiu X, et al. Mir-183 inhibits the metastasis of osteosarcoma via downregulation of the expression of ezrin in f5m2 cells. Int J Mol Med. 2012;30:1013–20.

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Shi XY, Gu L, Chen J, Guo XR, Shi YL. Downregulation of mir-183 inhibits apoptosis and enhances the invasive potential of endometrial stromal cells in endometriosis. Int J Mol Med. 2014;33:59–67.

    CAS  PubMed  Google Scholar 

  11. Sarver AL, Li L, Subramanian S. Microrna mir-183 functions as an oncogene by targeting the transcription factor egr1 and promoting tumor cell migration. Cancer Res. 2010;70:9570–80.

    Article  CAS  PubMed  Google Scholar 

  12. Lowery AJ, Miller N, Dwyer RM, Kerin MJ. Dysregulated mir-183 inhibits migration in breast cancer cells. BMC Cancer. 2010;10:502.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Yang M, Liu R, Li X, Liao J, Pu Y, Pan E, et al. Mirna-183 suppresses apoptosis and promotes proliferation in esophageal cancer by targeting pdcd4. Mol Cells. 2014;37:873–80.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Wang G, Mao W, Zheng S. Microrna-183 regulates ezrin expression in lung cancer cells. FEBS Lett. 2008;582:3663–8.

    Article  CAS  PubMed  Google Scholar 

  15. Gross DN, van den Heuvel AP, Birnbaum MJ. The role of foxo in the regulation of metabolism. Oncogene. 2008;27:2320–36.

    Article  CAS  PubMed  Google Scholar 

  16. Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH, Dosik H, et al. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst. 1973;51:1417–23.

    Article  CAS  PubMed  Google Scholar 

  17. Tian Z, Yao G, Song H, Zhou Y, Geng J. Igf2r expression is associated with the chemotherapy response and prognosis of patients with advanced nsclc. Cell Physiol Biochem. 2014;34:1578–88.

    Article  CAS  PubMed  Google Scholar 

  18. Shi C, Qian J, Ma M, Zhang Y, Han B. Notch 3 protein, not its gene polymorphism, is associated with the chemotherapy response and prognosis of advanced nsclc patients. Cell Physiol Biochem. 2014;34:743–52.

    Article  CAS  PubMed  Google Scholar 

  19. Song W, Li Q, Wang L, Wang L. Modulation of foxo1 expression by mir-21 to promote growth of pancreatic ductal adenocarcinoma. Cell Physiol Biochem. 2015;35:184–90.

    Article  CAS  PubMed  Google Scholar 

  20. Chang YW, Zhao YF, Cao YL, Gu XF, Li ZQ, Wang SQ, et al. Liver x receptor alpha inhibits osteosarcoma cell proliferation through up-regulation of foxo1. Cell Physiol Biochem. 2013;32:180–6.

    Article  CAS  PubMed  Google Scholar 

Download references

Conflicts of interest

None

Author information

Authors and Affiliations

  1. Department of Respiratory Diseases, Beijing Military Region General Hospital of PLA, 5 Nanmencang, Dongcheng District, Beijing, 100700, China

    Liqun Zhang, Sihai Wang, XueHui Li & Xiaoyu Che

  2. Battalion 19 of the Department of Biomedical Engineering, Third Military Medical University, Chongqing, 400038, China

    Hongyu Quan

Authors
  1. Liqun Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hongyu Quan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sihai Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. XueHui Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xiaoyu Che
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Liqun Zhang.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, L., Quan, H., Wang, S. et al. MiR-183 promotes growth of non-small cell lung cancer cells through FoxO1 inhibition. Tumor Biol. 36, 8121–8126 (2015). https://doi.org/10.1007/s13277-015-3550-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-015-3550-8

Keywords

Search

Navigation